–scent
发表于 2025-3-30 09:44:36
http://reply.papertrans.cn/20/1906/190570/190570_51.png
窃喜
发表于 2025-3-30 14:54:00
,Antibody–Drug Conjugates: A New Therapeutic Approach for Triple-Negative Breast Cancer,erapy. Despite recent advances in drug discovery, its management is still a challenge for clinicians, illuminating the unmet need to develop novel treatment approaches. Antibody–drug conjugates (ADC) are innovative oncology drugs that combine the specificity of monoclonal antibodies and the high eff
聪明
发表于 2025-3-30 17:10:56
http://reply.papertrans.cn/20/1906/190570/190570_53.png
animated
发表于 2025-3-30 23:10:47
http://reply.papertrans.cn/20/1906/190570/190570_54.png
Eclampsia
发表于 2025-3-31 01:35:28
http://reply.papertrans.cn/20/1906/190570/190570_55.png
Collected
发表于 2025-3-31 05:14:51
Assessment and Response to Neoadjuvant Treatments in Breast Cancer: Current Practice, Response Moniy, it was introduced 50 years ago to downsize locally advanced (inoperable) BCs. NAT are now widespread and so effective to be used also at the early stage of the disease. NAT are heterogeneous in terms of therapeutic patterns, class of used drugs, dosage, and duration. The poly-chemotherapy regimen
蒙太奇
发表于 2025-3-31 10:41:17
http://reply.papertrans.cn/20/1906/190570/190570_57.png